TFS
DGX icon

Thoroughbred Financial Services’s Quest Diagnostics DGX Stock Holding History

Thoroughbred Financial Services’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.95M Buy
9,212
+1
+0% +$196 0.09% 197
2026
Q1 		$1.8M Buy
9,211
+1
+0% +$194 0.11% 185
2025
Q4 		$1.6M Sell
9,210
-285
-3% -$51.9K 0.09% 196
2025
Q3 		$1.81M Buy
9,495
+177
+2% +$31.4K 0.11% 183
2025
Q2 		$1.67M Sell
9,318
-3,072
-25% -$534K 0.12% 181
2025
Q1 		$2.1M Sell
12,390
-66
-0.5% -$10.8K 0.13% 165
2024
Q4 		$1.88M Sell
12,456
-114
-0.9% -$17.7K 0.11% 168
2024
Q3 		$1.95M Sell
12,570
-444
-3% -$66.3K 0.13% 157
2024
Q2 		$1.78M Buy
13,014
+2,430
+23% +$333K 0.12% 167
2024
Q1 		$1.41M Sell
10,584
-4,844
-31% -$628K 0.14% 149
2023
Q4 		$2.13M Sell
15,428
-957
-6% -$126K 0.17% 124
2023
Q3 		$2M Buy
16,385
+3,827
+30% +$510K 0.2% 111
2023
Q2 		$1.76M Sell
12,558
-368
-3% -$50.7K 0.23% 101
2023
Q1 		$1.83M Buy
12,926
+1
+0% +$143 0.27% 96
2022
Q4 		$2.02M Sell
12,925
-98
-0.8% -$14.1K 0.33% 80
2022
Q3 		$1.6M Sell
13,023
-298
-2% -$39.2K 0.3% 84
2022
Q2 		$1.77M Sell
13,321
-163
-1% -$22.2K 0.33% 78
2022
Q1 		$1.84M Buy
13,484
+6,708
+99% +$935K 0.3% 77
2021
Q4 		$1.17M Buy
6,776
+510
+8% +$77.6K 0.25% 98
2021
Q3 		$910K Buy
6,266
+258
+4% +$37.8K 0.22% 109
2021
Q2 		$793K Buy
6,008
+459
+8% +$60.1K 0.2% 124
2021
Q1 		$712K Sell
5,549
-102
-2% -$12.6K 0.2% 124
2020
Q4 		$673K Buy
5,651
+179
+3% +$21.8K 0.21% 123
2020
Q3 		$626K Buy
5,472
+250
+5% +$29.5K 0.24% 113
2020
Q2 		$595K Sell
5,222
-7,764
-60% -$823K 0.25% 111
2020
Q1 		$1.04M Sell
12,986
-1,354
-9% -$140K 0.37% 82
2019
Q4 		$1.53M Sell
14,340
-2,076
-13% -$216K 0.51% 54
2019
Q3 		$1.76M Buy
16,416
+66
+0.4% +$6.78K 0.67% 41
2019
Q2 		$1.66M Sell
16,350
-25
-0.2% -$2.4K 0.63% 44
2019
Q1 		$1.47M Buy
16,375
+334
+2% +$28.9K 0.61% 48
2018
Q4 		$1.33M Buy
+16,041
New +$1.5M 0.66% 46

Other funds holding DGX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

Thoroughbred Financial Services's DGX Position: Q2 2026 in Review

Thoroughbred Financial Services increased its Quest Diagnostics (DGX) stake by 0.01% in Q2 2026, buying an estimated $196 and bringing the position to 9,212 shares worth $1.95M. The position accounts for 0.09% of the portfolio, ranked #197.

Thoroughbred Financial Services first reported a position in DGX in Q4 2018 and has held it in 31 quarters since. The position peaked at $2.13M in Q4 2023. 1,107 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • Thoroughbred Financial Services held 9,212 shares of Quest Diagnostics worth $1.95M as of Q2 2026.
  • Thoroughbred Financial Services bought 1 Quest Diagnostics share in Q2 2026, an estimated $196.
  • Quest Diagnostics made up 0.09% of Thoroughbred Financial Services's portfolio in Q2 2026, its #197 holding.
  • Thoroughbred Financial Services first reported a position in Quest Diagnostics in Q4 2018 and has held it in 31 quarters since.
  • Thoroughbred Financial Services's Quest Diagnostics position peaked at $2.13M in Q4 2023.
  • 1,107 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Thoroughbred Financial Services's 13F filing for Q2 2026, filed 11 Aug 2026.